The BASIC trial: Improving implementation of evidence-based approaches and surveillance to prevent bacterial transmission and infection

BASIC 试验:改进循证方法和监测的实施,以防止细菌传播和感染

基本信息

  • 批准号:
    10434139
  • 负责人:
  • 金额:
    $ 80.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-17 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

We propose to establish a best practice for implementation of a multifaceted approach designed to attenuate perioperative ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, Enterobacter spp.) transmission and associated surgical site infection (SSI) development. Perioperative ESKAPE transmission (inoculum) contributes to the development of surgical site infections (SSIs) which affect 3-5% of patients undergoing surgery. SSIs increase patient morbidity, prolong hospitalization, increase the risk of intensive care unit admission, and increase the risk of death 2-fold. ESKAPE pathogens are particularly problematic. Sustained reductions in epidemiologically-related, perioperative S. aureus transmission events achieved via a multi-faceted approach including surveillance feedback optimization resulted in substantial SSI reductions (88% decrease). An evidence-based approach for attenuation of the perioperative bacterial inoculum2 must integrate improvements in provider hand hygiene, intravascular catheter design/handling, environmental cleaning/organization, and patient decolonization. In this application, we propose a type 1 hybrid effectiveness-implementation using a 2x2 factorial cluster-randomized design guided by RE-AIM. We aim to identify a best practice for addressing the perioperative ESKAPE inoculum. We will examine the relative effectiveness of increased site awareness and commitment to generating improvements via technical assistance (TA), team coaching implementation of an evidence-based set of interventions (EBIP), and TA or EBIP with ESKAPE transmission surveillance feedback. Our strong preliminary data from a randomized trial implementing a multifaceted program with surveillance has demonstrated substantial and statistically significant reductions in transmission of S. aureus and 90-day SSIs and recently reproduced our randomized trial findings in an additional external site. Therefore, our prior research strongly suggests that the proposed research should be done and justifies scaling up to dissemination and implementation. Our exceptional multidisciplinary team is well equipped to successfully complete the proposed trial and aims. In the proposed trial guided by RE-AIM, we will advance scientific knowledge and inform future dissemination and implementation by investigating how best to scale-up an already successful multifaceted approach to national dissemination through either TA or EBIP with or without surveillance. We will conduct a rigorous cost- effectiveness analysis including evaluation of net cost savings. The proposed trial guided by RE-AIM (Aim 1), the addition of 1-year follow-up for sustainability (Aim 2), and cost-effectiveness analysis (Aim 3) will provide the essential scientific knowledge to adopters and organizers to be able to reproduce the most effective delivery method of our interventions to their local setting in addition to informing our investigative team which approach to scale-up to reach national dissemination.
我们建议建立一个最佳实践,以实施旨在减轻的多方面方法

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeremiah R Brown其他文献

Measuring Neurite Dynamics in Co-culture Using IncuCyte ZOOM ® Live-content Imaging Platform and NeuroLight Red TM Fluorescent Label
使用 IncuCyte ZOOM ® 实时内容成像平台和 NeuroLight Red TM 荧光标签测量共培养中的神经节动态
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jeremiah R Brown;T. Garay;S. Alcantara;Lauren T McGillicuddy;Nevine Holtz;J. Rauch;Dyke;McEwen;V. Groppi;T. Dale;O. McManus
  • 通讯作者:
    O. McManus
Optimizing the pharmacoinvasive approach to acute ST-segment elevation myocardial infarction: use of half-dose thrombolytic therapy in combination with glycoprotein IIb/IIIa receptor inhibitors compared with full-dose thrombolytic therapy in the setting of routine urgent post-thrombolytic percutaneous coronary intervention
  • DOI:
    10.1016/j.carrev.2010.03.053
  • 发表时间:
    2010-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Pantila Vanichakarn;Rayson C. Yang;Sheila M. Conley;Tamara A. Anderson;James T. Devries;Bruce J. Friedman;Bruce D. Hettleman;John E. Jayne;Aaron V. Kaplan;John F. Robb;Jeremiah R Brown;Nathaniel W. Niles
  • 通讯作者:
    Nathaniel W. Niles

Jeremiah R Brown的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeremiah R Brown', 18)}}的其他基金

The BASIC trial: Improving implementation of evidence-based approaches and surveillance to prevent bacterial transmission and infection
BASIC 试验:改进循证方法和监测的实施,以防止细菌传播和感染
  • 批准号:
    10618922
  • 财政年份:
    2021
  • 资助金额:
    $ 80.55万
  • 项目类别:
The BASIC trial: Improving implementation of evidence-based approaches and surveillance to prevent bacterial transmission and infection
BASIC 试验:改进循证方法和监测的实施,以防止细菌传播和感染
  • 批准号:
    10316780
  • 财政年份:
    2021
  • 资助金额:
    $ 80.55万
  • 项目类别:
DeepCOPD: Development and Implementation of Deep Learning to Predict and Prevent COPD Health Care Encounters
DeepCOPD:开发和实施深度学习来预测和预防慢性阻塞性肺病医疗保健遭遇
  • 批准号:
    10542393
  • 财政年份:
    2021
  • 资助金额:
    $ 80.55万
  • 项目类别:
DeepCOPD: Development and Implementation of Deep Learning to Predict and Prevent COPD Health Care Encounters
DeepCOPD:开发和实施深度学习来预测和预防慢性阻塞性肺病医疗保健遭遇
  • 批准号:
    10382949
  • 财政年份:
    2021
  • 资助金额:
    $ 80.55万
  • 项目类别:
IMPROVE AKI: A Cluster-Randomized Trial of Team-Based Coaching Interventions to IMPROVE Acute Kidney Injury
改善 AKI:基于团队的教练干预改善急性肾损伤的整群随机试验
  • 批准号:
    10402326
  • 财政年份:
    2018
  • 资助金额:
    $ 80.55万
  • 项目类别:
Information Extraction from EMRs to Predict Readmission following Acute Myocardial Infarction
从 EMR 中提取信息以预测急性心肌梗死后的再入院
  • 批准号:
    9282479
  • 财政年份:
    2016
  • 资助金额:
    $ 80.55万
  • 项目类别:
Novel Biomarkers to Predict Readmission in Pediatric and Adult Heart Surgery
预测儿童和成人心脏手术再入院的新型生物标志物
  • 批准号:
    9098842
  • 财政年份:
    2014
  • 资助金额:
    $ 80.55万
  • 项目类别:
Novel Biomarkers to Predict Readmission in Pediatric and Adult Heart Surgery
预测儿童和成人心脏手术再入院的新型生物标志物
  • 批准号:
    8759821
  • 财政年份:
    2014
  • 资助金额:
    $ 80.55万
  • 项目类别:
Patient Safety and Acute Kidney Injury
患者安全和急性肾损伤
  • 批准号:
    8274314
  • 财政年份:
    2009
  • 资助金额:
    $ 80.55万
  • 项目类别:
Patient Safety and Acute Kidney Injury
患者安全和急性肾损伤
  • 批准号:
    7786118
  • 财政年份:
    2009
  • 资助金额:
    $ 80.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 80.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了